Viva Biotech Holdings (HK:1873) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Viva Biotech Holdings has successfully adopted its Viva Shanghai Phase I and Phase II Share Option Schemes, with shareholders’ approval leading to the immediate effectivity of both schemes. The company has updated its share option grants, now extending 7,320,000 Phase I and Phase II share options to 11 and 21 incentive participants respectively, with slight adjustments due to personnel changes. These grants are set to be formalized and implemented for the incentive participants on June 14, 2024.
For further insights into HK:1873 stock, check out TipRanks’ Stock Analysis page.